ArticleInternational journal of clinical and experimental pathology2020

EphA2, a possible target of miR-200a, functions through the AKT2 pathway in human lung carcinoma.

Hiroyoshi Tsubochi et al.PubMed ↗Full text ↗

No numbers read from the abstract.